Aerie Pharmaceuticals, Inc. Accrued Liabilities, Current
Aerie Pharmaceuticals, Inc. had Accrued Liabilities, Current of $119.40 million as of 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2022-11-04
- 2022-09-30: Accrued Liabilities, Current $119.40M.
- 2022-06-30: Accrued Liabilities, Current $105.64M.
- 2022-03-31: Accrued Liabilities, Current $102.95M.
- 2021-12-31: Accrued Liabilities, Current $112.34M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2022-09-30 | $119.40M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $105.64M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $102.95M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $112.34M 10-Q · filed 2022-11-04 |
| 2021-09-30 | $106.12M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $96.76M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $82.79M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $90.72M 10-K · filed 2022-02-25 |
| 2020-09-30 | $78.81M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $71.89M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $64.32M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $65.38M 10-K · filed 2021-02-26 |
| 2019-09-30 | $55.73M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $46.52M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $35.81M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $38.38M 10-K · filed 2020-02-24 |
| 2018-09-30 | $27.95M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $20.02M 10-Q · filed 2018-08-09 |
| 2017-12-31 | $18.94M 10-K · filed 2019-03-01 |